A Tumour-Aware Multimodal Framework for Explainable Prediction of IDH Mutation in Gliomas from Multi-Sequence MRI
Authors: Tahsien Al-Quraishi, Waseem Alwan Zaboon, O. S. Albahri, Raza Nowrozy
Organizations: School of Business, Melbourne Institute of Technology, Melbourne, 3000, Victoria, Australia · Al-Ayen Iraqi University, Nasiriyah, Iraq · Mechanical Engineering Department, College of Engineering, Wasit University, Al Kut, Iraq · Federation University Australia, Ballarat, Victoria, Australia · College of Art, Business, Law, Education and IT (CoABLEIT), Victoria University, Melbourne, 3000, Victoria, Australia
Accurate prediction of isocitrate dehydrogenase (IDH) mutation status is essential for glioma diagnosis, prognosis, and treatment planning. Although recent deep learning approaches have demonstrated promising performance, many rely on whole-brain feature extraction and provide limited interpretability. This study proposes a tumour-aware multimodal framework for explainable, non-invasive prediction of IDH mutation status from multiparametric magnetic resonance imaging (MRI). The proposed framework integrates four MRI sequences (T1, T1CE, T2, and FLAIR), tumour subregion segmentation, quantitative radiomic descriptors, and clinical information within a unified deep learning architecture. An ablation study was conducted to evaluate the contribution of tumour-aware learning, radiomic features, and clinical variables. Model performance was assessed using multiple complementary evaluation metrics, including accuracy, precision, recall, F1-score, balanced accuracy, receiver operating characteristic analysis, confusion matrix evaluation, and Grad-CAM visualisation. Experimental results demonstrated that the proposed multimodal framework consistently outperformed the baseline MRI-only model, with the Clinical Fusion model achieving the strongest overall predictive performance. The integration of tumour-aware learning, radiomic descriptors, and clinical information progressively improved classification performance, while Grad-CAM visualisations indicated that the model predominantly focused on biologically relevant tumour regions. These findings suggest that tumour-aware multimodal feature integration enables accurate, interpretable, and non-invasive molecular profiling of gliomas and provides a promising foundation for future clinical decision support in precision neuro-oncology.
Figures & tables
Study
Year
DL
TA
Rad
Clin
XAI
EV
Key Innovation
Choi et al. [ 25 ]
2021
✓
✓
✓
×
×
✓
Fully automated CNN–radiomics framework
Cluceru et al. [ 26 ]
2022
✓
×
×
×
×
×
Deep learning for WHO 2021 molecular glioma classification
Truong et al. [ 37 ]
2024
△
✓
✓
×
×
✓
Two-stage multicontrast MRI radiomics
Lost et al. [ 38 ]
2024
×
×
✓
×
×
✓
Externally validated radiomics model
Siddiqui et al. [ 31 ]
2025
✓
×
△
×
×
×
Hybrid whole-brain MRI framework
Niu et al. [ 28 ]
2025
✓
×
✓
×
×
✓
Transformer–radiomics fusion
Table 1: Comparison of MRI-based IDH mutation prediction methods
Characteristic
Value
Original cohort size
625
Excluded (missing IDH status)
3
Final cohort size
622
Age (years)
55.0 ± 15.5 (18–85)
Male
369 (59.3%)
Female
253 (40.7%)
Table 2: Characteristics of the study cohort
Figure 1: Distribution of IDH mutation status in the study cohort
Figure 2: Age distribution of patients included in the study cohort.
Figure 3: Distribution of tumour grades in the study cohort.
Figure 4: Sex distribution of patients included in the study cohort.
Figure 5: Distribution of IDH mutation status across tumour grades.
Figure 6: Percentage of IDH mutation status within each tumour grade.
Figure 7: Representative tumour segmentation mask
Figure 8: Representative T1CE MRI and tumour segmentation mask
Figure 9: Overview of the proposed tumour-aware multimodal framework.
Model
Accuracy (%)
Precision (%)
Recall (%)
F1-score (%)
AUC
Baseline CNN
64.89
40.63
48.15
44.07
0.684
No-Grade Ensemble
80.85
62.86
81.48
70.97
0.895
Radiomics Fusion
80.85
62.16
85.19
71.88
0.917
Clinical Fusion
86.17
70.59
88.89
78.69
0.944
Table 3: Performance comparison of the evaluated models for IDH mutation prediction.
Configuration
Components Included
Baseline CNN
MRI only
Tumour-aware Ensemble
MRI + Tumour-aware learning
Radiomics Fusion
MRI + Tumour-aware learning + Radiomic features
Clinical Fusion (Proposed)
MRI + Tumour-aware learning + Radiomic features + Clinical variables
Table 4: Ablation configurations of the proposed multimodal framework.
Figure 10: ROC curves of the evaluated models for IDH mutation prediction.
Figure 11: Confusion matrix of the proposed Clinical Fusion model
Figure 12: Tumour-focused saliency analysis of the proposed Clinical Fusion model.
Abbreviation
Definition
AI
Artificial Intelligence
AUC
Area Under the Receiver Operating Characteristic Curve
BraTS
Brain Tumor Segmentation Challenge
CNN
Convolutional Neural Network
FLAIR
Fluid-Attenuated Inversion Recovery
F1-score
Harmonic Mean of Precision and Recall
Table 5: List of abbreviations used in this study.
Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, South Korea · Interdisciplinary Program in Cancer Biology, Seoul National University College of Medicine, Seoul, South Korea · Dept. of Biomedical Sciences, Seoul National University, Seoul, South Korea +4